Wird geladen...
Using Small-Molecule Adjuvants to Repurpose Azithromycin for Use against Pseudomonas aeruginosa
A major contributor to fatalities in cystic fibrosis (CF) patients stems from infection with opportunistic bacterium Pseudomonas aeruginosa. As a result of the CF patient’s vulnerability to bacterial infections, one of the main treatment focuses is antibiotic therapy. However, the highly adaptive na...
Gespeichert in:
| Veröffentlicht in: | ACS Infect Dis |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6716366/ https://ncbi.nlm.nih.gov/pubmed/30444345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsinfecdis.8b00288 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|